相关实验视频

Updated: Jun 8, 2025

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Published on: July 26, 2011

通过控制溶酶体生物发生和酸化,ROCK1在AD病原发生中的关键作用

Chenghuan Song¹, Wanying Huang¹, Pingao Zhang¹

¹Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Translational neurodegeneration

|November 4, 2024

概括

这项研究确定ROCK1是阿尔茨海默氏症 (AD) 中 lysosomal 功能的关键调节者. 抑制ROCK1可以改善溶酶体活性和Aβ清除,为AD提供潜在的治疗点.

科学领域:

神经科学是一个神经科学.
细胞生物学细胞生物学
分子生物学分子生物学

背景情况:

溶解体平衡对于神经细胞的生存至关重要.
功能障碍的溶解体有助于阿尔茨海默病 (AD) 的发病,导致神经退行.
在阿尔茨海默病中调节 lysosomal homeostasis 的机制尚未完全理解.

研究的目的:

调查ROCK1在溶酶体平衡中的作用及其对阿尔茨海默病的影响.
阐明AD中涉及ROCK1和TFEB的调节途径.

主要方法:

在死后AD大脑中检查了ROCK1表达.
评估了ROCK1对神经细胞中 lysosomal生物发生和酸化的影响.
在AD小鼠模型中研究了ROCK1-TFEB相互作用及其功能后果.

主要成果:

在AD大脑中,ROCK1水平升高,与溶酶体功能障碍和粉样β (Aβ) 病理相关.
抑制ROCK1可恢复 lysosomal 功能,并增强神经元和微质中的Aβ清除.
ROCK1充当TFEB的上游激酶,促进AD病变发生的恶性循环.

结论:

在阿尔茨海默病中,ROCK1在溶酶体功能障碍和Aβ清除中发挥着关键作用.
ROCK1被确定为TFEB的一个新的上游血清激酶.
向ROCK1可能通过恢复 lysosomal 功能为阿尔茨海默病提供治疗策略.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.Lysosomal 酸性化发生的原因 lysosomal生物发生的过程.在Rock1上,你会看到Rock1.美国联邦税务法 (TFEB)

更多相关视频

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...